Utilization Management
Prior Authorization, Step Therapy, and Quantity Limit Policies for CareSource Marketplace Business
Not all medications will be covered on the formulary. Non-formulary medications are subject to the Medical Necessity for Non-Formulary Medications policy. Please consult the formulary to verify coverage.
| Repository Corticotropin - Cortrophin Gel PA Policy De-Identified | Policy |
| Rituximab Intravenous Products PA Policy De-Identified | Policy |
| Rituximab Intravenous Products PSM Policy De-Identified | Policy |
| Scenesse PA Policy De-Identified | Policy |
| Sedative Hypnotics DQM Policy - Per Days De-Identified | Policy |
| Sedative Hypnotics Step Therapy Policy De-Identified | Policy |
| Sickle Cell Disease - Adakveo PA Policy De-Identified | Policy |
| Sickle Cell Disease - Endari PA Policy De-Identified | Policy |
| Sickle Cell Disease - Hydroxyurea Products Preferred Step Therapy Policy De-Identified | Policy |
| Sickle Cell Disease - Oxbryta DQM Policy - Per Rx De-Identified | Policy |
| Sickle Cell Disease - Oxbryta PA Policy De-Identified | Policy |
| Somatostatin Analogs - Mycapssa PA Policy De-Identified | Policy |
| Somatostatin Analogs – Octreotide Immediate-Release Products PA Policy De-Identified | Policy |
| Somatostatin Analogs – Octreotide Immediate-Release Products PSM Policy De-Identified | Policy |
| Somatostatin Analogs – Sandostatin LAR Depot PA Policy De-Identified | Policy |
| Somatostatin Analogs – Signifor LAR PA Policy De-Identified | Policy |
| Somatostatin Analogs for Acromegaly PSM Policy De-Identified | Policy |
| Somavert PA Policy De-Identified | Policy |
| Spinal Muscular Atrophy - Evrysdi PA Policy De-Identified | Policy |
| Spinal Muscular Atrophy - Spinraza DQM Policy - Per Days De-Identified | Policy |
| Spinal Muscular Atrophy - Spinraza PA Policy De-Identified | Policy |
| Spinal Muscular Atrophy - Zolgensma PA Policy De-Identified | Policy |
| Synagis PA Policy De-Identified | Policy |
| Tasimelteon Products PA Policy De-Identified | Policy |
| Testosterone (injectable) Products PA Policy De-Identified | Policy |
| Testosterone (Oral, Topical, and Nasal) Products PA Policy De-Identified | Policy |
| Testosterone Products (Topical) DQM Policy - Per Rx De-Identified | Policy |
| Testosterone Undecanoate (Oral) DQM Policy - Per Rx De-Identified | Policy |
| Tetracyclines (Oral) Step Therapy Policy De-Identified | Policy |
| Thrombocytopenia - Doptelet DQM Policy - Per Rx De-Identified | Policy |
| Thrombocytopenia - Doptelet PA Policy De-Identified | Policy |
| Thrombocytopenia - Mulpleta PA Policy De-Identified | Policy |
| Thrombocytopenia - Nplate PA Policy De-Identified | Policy |
| Thrombocytopenia - Promacta PA Policy De-Identified | Policy |
| Thrombocytopenia - Tavalisse PA Policy De-Identified | Policy |
| Tolvaptan Products - Jynarque PA Policy De-Identified | Policy |
| Tolvaptan Products - Tolvaptan (Samsca) PA Policy De-Identified | Policy |
| Tolvaptan Products DQM Policy - Per Rx De-Identified | Policy |
| Topical Acne - Cleansers Step Therapy Policy De-Identified | Policy |
| Topical Acne - Kits Step Therapy Policy De-Identified | Policy |
| Topical Acne - Topical Products Step Therapy Policy De-Identified | Policy |
| Topical Acne - Winlevi PA Policy De-Identified | Policy |
| Topical Acyclovir Products PA Policy De-Identified | Policy |
| Topical Agents for Atopic Dermatitis DQM Policy - Per Days De-Identified | Policy |
| Topical Agents for Atopic Dermatitis Step Therapy Policy De-Identified | Policy |
| Topical Alpha-Adrenergic Agonists for Rosacea - Brimonidine PA with Step Therapy Policy De-Identified | Policy |
| Topical Alpha-Adrenergic Agonists for Rosacea - Rhofade PA Policy De-Identified | Policy |
| Topical Anesthetics DQM Policy - Per Days De-Identified | Policy |
| Topical Antibacterials Step Therapy Policy De-Identified | Policy |
| Topical Antibiotics for Acne - Clindamycin DQM Policy - Per Days De-Identified | Policy |
| Topical Antifungals DQM Policy - Per Days De-Identified | Policy |
| Topical Antifungals for Onychomycosis Step Therapy Policy De-Identified | Policy |
| Topical Antipruritics - Doxepin Products DQM Policy - Per Days De-Identified | Policy |
| Topical Calcipotriene Products DQM Policy - Per Days De-Identified | Policy |
| Topical Collagenase - Santyl DQM Policy - Per Rx De-Identified | Policy |
| Topical Corticosteroids - Clobetasol DQM Policy - Per Days De-Identified | Policy |
| Topical Corticosteroids - Diflorasone DQM Policy - Per Days De-Identified | Policy |
| Topical Corticosteroids - Fluocinonide DQM Policy - Per Days De-Identified | Policy |
| Topical Corticosteroids - Flurandrenolide DQM Policy - Per Days De-Identified | Policy |
| Topical Corticosteroids - Hydrocortisone Butyrate DQM Policy - Per Days De-Identified | Policy |
| Topical Corticosteroids - Triamcinolone Spray DQM Policy - Per Days De-Identified | Policy |
| Topical Corticosteroids Step Therapy Policy De-Identified | Policy |
| Topical Diclofenac Sodium 3 percent Gel PA Policy De-Identified | Policy |
| Topical Doxepin Step Therapy Policy De-Identified | Policy |
| Topical Medications for Inflammatory Rosacea Step Therapy De-Identified | Policy |
| Topical Podofilox Products Step Therapy Policy De-Identified | Policy |
| Topical Products - Vtama and Zoryve Step Therapy Policy De-Identified | Policy |
| Topical Retinoids - Aklief PA Policy De-Identified | Policy |
| Topical Retinoids - Panretin PA Policy De-Identified | Policy |
| Topical Retinoids - Tazarotene Products PA Policy De-Identified | Policy |
| Topical Retinoids - Tretinoin Products PA Policy De-Identified | Policy |
| Topical Vitamin D Analogs Step Therapy Policy De-Identified | Policy |
| Uplizna PA Policy De-Identified | Policy |
| Vasculitis - Tavneos PA Policy De-Identified | Policy |
| Vecamyl PA Policy De-Identified | Policy |
| Veregen PA Policy De-Identified | Policy |
| Vesicular Monoamine Transporter Type 2 Inhibitors - Austedo PA Policy De-Identified | Policy |
| Vesicular Monoamine Transporter Type 2 Inhibitors - Ingrezza PA Policy De-Identified | Policy |
| Vesicular Monoamine Transporter Type 2 Inhibitors - Tetrabenazine PA Policy De-Identified | Policy |
| Vesicular Monoamine Transporter Type 2 Inhibitors DQM Policy - Per Rx De-Identified | Policy |
| Vesicular Monoamine Transporter Type 2 Inhibitors PSM Policy De-Identified | Policy |
| Vijoice PA Policy De-Identified | Policy |
| Vitamin B12 (Cyanocobalamin) Products Step Therapy Policy De-Identified | Policy |
| Vitamin D Analog (Oral) Step Therapy Policy De-Identified | Policy |
| Wakefulness-Promoting Agents - Sunosi DQM Policy - Per Rx De-Identified | Policy |
| Wakefulness-Promoting Agents – Wakix DQM Policy – Per Rx De-Identified | Policy |
| Xiaflex PA Policy De-Identified | Policy |
| Zavesca Market Events Clinical Policy De-Identified | Policy |
| Zokinvy PA Policy De-Identified | Policy |